Neuroendocrine prostate cancer (NEPC) is a highly aggressive subtype of prostate cancer
(PC) that commonly emerges through a transdifferentiation process from prostate …

Background Rapid evolution of the therapeutic management of prostate cancer, especially
in in second-generation androgen inhibitors, has increased the opportunity of transformation …

Neuroendocrine prostate cancer (NEPC) is a lethal subtype of prostate cancer. NEPC arises
de novo only rarely; the disease predominantly develops from adenocarcinoma in response …

Our understanding of neuroendocrine prostate cancer (NEPC) has assumed a new
perspective in light of the recent advances in research. Although classical NEPC is rarely …

In normal prostate, neuroendocrine (NE) cells are rare and interspersed among the
epithelium. These cells are believed to provide trophic signals to epithelial cell populations …

Worldwide, prostate cancer (PCa) remains a leading cause of death in men. Histologically,
the majority of PCa cases are classified as adenocarcinomas, which are mainly composed …

Neuroendocrine prostate cancer (NEPC) is an aggressive variant of prostate cancer that
commonly arises in later stages of castration resistant prostate cancer (CRPC) The detection …

Abstract Purpose of Review Neuroendocrine prostate cancer (NEPC) is an aggressive
histologic subtype of prostate cancer that most commonly arises in later stages of prostate …

Prostate cancer is the most common non-cutaneous cancer and the second leading cause
of cancer-associated deaths among men in the United States. Androgen deprivation therapy …

Prostate cancer is the most common cancer among men and has a high incidence and
associated mortality worldwide. It is an androgen-driven disease in which tumor growth is …